Executive Wealth Management »

Global X Fds genomic biotech shares owned by Executive Wealth Management

Quarter-by-quarter ownership of Global X Fds genomic biotech (GNOM) shares owned by Executive Wealth Management from 13F filings

Historical chart of Executive Wealth Management investment in Global X Fds genomic biotech

Tip: Access up to 7 years of quarterly data

All positions including Global X Fds genomic biotech held by Executive Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Global X Fds genomic biotech by Executive Wealth Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $118k 12k 9.71

More positions owned by Executive Wealth Management

Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Goldman Sachs Etf Tr Access Invt Gr (GIGB)
Apple (AAPL)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Spdr Ser Tr Portfolio S&p500 (SPLG)
NVIDIA Corporation (NVDA)
American Centy Etf Tr Intl Eqt Etf (AVDE)
Microsoft Corporation (MSFT)
Ishares Tr Msci Usa Min Vol (USMV)
Ishares Tr Core S&p Scp Etf (IJR)
Angel Oak Funds Trust Income Etf (CARY)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)

View all positions for Executive Wealth Management

Top funds holding Global X Fds genomic biotech

Morgan Stanley
IFP Advisors
Advisor Group Holdings
Global Retirement Partners
Ronald Blue Trust

View all funds holding Global X Fds genomic biotech